Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
Participants who took the 25 mg oral dose and stuck to the protocol lost an average of 1316.6% of their body weight over 64 weeks
A clinical trial of once-weekly TZT in T2DM patients illustrated that at 26 weeks of treatment, TZT led to the significant reduction of intercellular adhesion molecule 1 (ICAM-1), growth differentiation factor 15 (GDF-15), chitosan-3 like protein 1 (YKL-40), leptin and CRP compared to the baseline values
In the STEP 2 trial, adults with obesity or overweight plus type 2 diabetes lost a mean 9.6% of their body weight at 68 weeks with semaglutide 2.4 mg vs
Semaglutide, tirzepatide, and liraglutide are FDA-approved for diabetes and weight management only
Educational only, not personal medical advice
US$ 24.29
US$ 27.80
US$ 21.28
US$ 26.92
US$ 20.53
